$CRVO SURGING 🚀 +28% Premarket! 🔹 Big move after CervoMed announced new AD/PD 2026 data reinforcing neflamapimod’s positive effects in Dementia with Lewy Bodi

$CRVO SURGING 🚀 +28% Premarket! 🔹 Big move after CervoMed announced new AD/PD 2026 data reinforcing neflamapimod’s positive effects in Dementia with Lewy Bodies 🧠 🔹 Data showed stronger clinical benefit in DLB patients without Alzheimer’s co-pathology — a key patient-enrichment angle for future …